IQE Regulatory News (IQE)

IQE plc

Cardiff, UK

6 February 2024

Block Admission

IQE plc (AIM: IQE, "IQE" or the "Group"), the leading global supplier of compound semiconductor wafer products and advanced material solutions, today announces an application has been made to the London Stock Exchange for a block admission of 16,000,000 ordinary shares of 1p each in the Company ("Ordinary Shares") to trading on AIM, to satisfy obligations under the Company's existing Long Term Incentive Plan which was approved by shareholders in 2019. The Long Term Incentive Plan is currently used to incentivise all of IQE's employees on an annual basis.

The Ordinary Shares held under the block admission will be allotted and issued in due course in accordance with the rules of the respective scheme(s) and will rank pari passu in all respects with the existing Ordinary Shares in issue. It is expected that admission of the Ordinary Shares under the block admission will become effective at 8.00 am on 7 February 2024. The new Ordinary Shares will be added to the balance of 5,518,704 Ordinary Shares remaining from the previous block admission. There is no change to the Group's issued share capital as a result of the Block Admission.

Contacts:

IQE plc

+44 (0) 29 2083 9400

Americo Lemos

Jutta Meier

Amy Barlow

Peel Hunt (Nomad and Joint Broker)

+44 (0) 20 7418 8900

Paul Gillam

Richard Chambers

Kate Bannatyne

Deutsche Numis (Joint Broker)

+44 (0) 20 7260 1000

Simon Willis

Hugo Rubinstein

Iqra Amin

Headland Consultancy (Financial PR) + 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Chloe Francklin: +44 (0)78 3497 4624

ABOUT IQE

http://iqep.com

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

· Smart Connected Devices

· Communications Infrastructure

· Automotive and Industrial

· Aerospace and Security

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the global market and is enabling customers to innovate at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with employees across eight manufacturing locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in London.